Application Sponsors
ANDA 214222 | GLAND PHARMA LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 15MG/VIAL | 0 | THIOTEPA | THIOTEPA |
002 | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 100MG/VIAL | 0 | THIOTEPA | THIOTEPA |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-03-08 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
CDER Filings
GLAND PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 214222
[companyName] => GLAND PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"THIOTEPA","activeIngredients":"THIOTEPA","strength":"15MG\/VIAL","dosageForm":"POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/08\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-03-08
)
)